Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1370448
PUBLISHER: IMARC | PRODUCT CODE: 1370448
Veterinary Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
PUBLISHED:
PAGES: 139 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Abstract
Market Overview:
The global veterinary vaccines market size reached US$ 12.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 21.5 Billion by 2028, exhibiting a growth rate (CAGR) of 9.3% during 2023-2028.
Veterinary vaccines represent bio-prepared immunizations that are administered to domestic animals or wild species through parenteral and oral routes to stimulate protective immune responses without causing the disease itself. They involve inactivated, live attenuated and recombinant vaccines as some common medications. These inoculations aid in reducing animal suffering, enhancing immune efficiency, and preventing the risk of developing and transmitting various contagious zoonotic diseases. Apart from this, veterinary vaccines are cost-effective, reliable, and offer long-term prevention, due to which they are also used to increase the production of livestock across the globe.
Veterinary Vaccines Market Trends:
The global veterinary vaccines market is majorly driven by the increasing demand for effective immunization products and the rising prevalence of various infectious epizootic disorders. This can be further attributed to the domestication of both companion and livestock animals across the globe and the enhanced focus on pet health. In line with this, extensive investments by governments in the pharmaceutical sector to improve novel veterinary vaccine manufacturing procedures are acting as another growth-inducing factor. Additionally, the introduction of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) vaccines with improved product stability, efficacy, and route administration approach is contributing to the market growth. Besides this, the innovation of intramuscular needle-free vaccine injections and growing awareness amongst consumers regarding their beneficial properties, such as enhanced safety and less pain, is propelling the market growth. Moreover, the fueling need for veterinary vaccines to prevent the transmission of disease-carrying microbes from livestock-based products, including milk, meat, leather, eggs, and wool, is positively stimulating the market growth. Other factors, such as significant improvements in the healthcare infrastructure, ongoing research and development (R&D) activities, and strategic collaborations amongst key players to enhance the efficiency of veterinary vaccines, are creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global veterinary vaccines market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on vaccine type, technology, route of administration and distribution channel.
Breakup by Vaccine Type:
Livestock Vaccines
Bovine Vaccines
Poultry Vaccines
Porcine Vaccines
Others
Companion Animal Vaccines
Canine Vaccines
Feline Vaccines
Equine Vaccines
Breakup by Technology:
Attenuated Live Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Others
Breakup by Route of Administration:
Subcutaneous
Intramuscular
Intranasal
Breakup by Distribution Channel:
Veterinary Hospitals
Veterinary Clinics
Pharmacies and Drug Stores
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Incorporated, Hester Biosciences Limited, HIPRA, Indian Immunologicals Limited, Merck & Co. Inc., Neogen Corporation, Phibro Animal Health Corporation, Virbac SA and Zoetis Inc.
Key Questions Answered in This Report:
- How has the global veterinary vaccines market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global veterinary vaccines market?
- What are the key regional markets?
- What is the breakup of the market based on the vaccine type?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the route of administration?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global veterinary vaccines market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112023A6493
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Veterinary Vaccines Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Vaccine Type
- 6.1 Livestock Vaccines
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Bovine Vaccines
- 6.1.2.2 Poultry Vaccines
- 6.1.2.3 Porcine Vaccines
- 6.1.2.4 Others
- 6.1.3 Market Forecast
- 6.2 Companion Animal Vaccines
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Canine Vaccines
- 6.2.2.2 Feline Vaccines
- 6.2.2.3 Equine Vaccines
- 6.2.3 Market Forecast
7 Market Breakup by Technology
- 7.1 Attenuated Live Vaccines
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Inactivated Vaccines
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Toxoid Vaccines
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Recombinant Vaccines
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by Route of Administration
- 8.1 Subcutaneous
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Intramuscular
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Intranasal
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Distribution Channel
- 9.1 Veterinary Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Veterinary Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Pharmacies and Drug Stores
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Boehringer Ingelheim International GmbH
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 Ceva Sante Animale
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Elanco Animal Health Incorporated
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.4 Hester Biosciences Limited
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.5 HIPRA
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Indian Immunologicals Limited
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Merck & Co. Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.8 Neogen Corporation
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Phibro Animal Health Corporation
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Virbac SA
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.11 Zoetis Inc.
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.1 Boehringer Ingelheim International GmbH
Product Code: SR112023A6493
List of Figures
- Figure 1: Global: Veterinary Vaccines Market: Major Drivers and Challenges
- Figure 2: Global: Veterinary Vaccines Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Veterinary Vaccines Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Veterinary Vaccines Market: Breakup by Vaccine Type (in %), 2022
- Figure 5: Global: Veterinary Vaccines Market: Breakup by Technology (in %), 2022
- Figure 6: Global: Veterinary Vaccines Market: Breakup by Route of Administration (in %), 2022
- Figure 7: Global: Veterinary Vaccines Market: Breakup by Distribution Channel (in %), 2022
- Figure 8: Global: Veterinary Vaccines Market: Breakup by Region (in %), 2022
- Figure 9: Global: Veterinary Vaccines (Livestock Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 10: Global: Veterinary Vaccines (Livestock Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 11: Global: Veterinary Vaccines (Companion Animal Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 12: Global: Veterinary Vaccines (Companion Animal Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 13: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 14: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 15: Global: Veterinary Vaccines (Inactivated Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 16: Global: Veterinary Vaccines (Inactivated Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 17: Global: Veterinary Vaccines (Toxoid Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 18: Global: Veterinary Vaccines (Toxoid Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 19: Global: Veterinary Vaccines (Recombinant Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 20: Global: Veterinary Vaccines (Recombinant Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 21: Global: Veterinary Vaccines (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 22: Global: Veterinary Vaccines (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 23: Global: Veterinary Vaccines (Subcutaneous) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 24: Global: Veterinary Vaccines (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 25: Global: Veterinary Vaccines (Intramuscular) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 26: Global: Veterinary Vaccines (Intramuscular) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 27: Global: Veterinary Vaccines (Intranasal) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 28: Global: Veterinary Vaccines (Intranasal) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 29: Global: Veterinary Vaccines (Veterinary Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 30: Global: Veterinary Vaccines (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 31: Global: Veterinary Vaccines (Veterinary Clinics) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 32: Global: Veterinary Vaccines (Veterinary Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 33: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 34: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 35: Global: Veterinary Vaccines (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 36: Global: Veterinary Vaccines (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 37: North America: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 38: North America: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 39: United States: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 40: United States: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 41: Canada: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 42: Canada: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 43: Asia-Pacific: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 44: Asia-Pacific: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 45: China: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 46: China: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 47: Japan: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 48: Japan: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 49: India: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 50: India: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 51: South Korea: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 52: South Korea: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 53: Australia: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 54: Australia: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 55: Indonesia: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 56: Indonesia: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 57: Others: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 58: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 59: Europe: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 60: Europe: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 61: Germany: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 62: Germany: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 63: France: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 64: France: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 65: United Kingdom: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 66: United Kingdom: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 67: Italy: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 68: Italy: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 69: Spain: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 70: Spain: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 71: Russia: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 72: Russia: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 73: Others: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 74: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 75: Latin America: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 76: Latin America: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 77: Brazil: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 78: Brazil: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 79: Mexico: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 80: Mexico: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 81: Others: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 82: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 83: Middle East and Africa: Veterinary Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 84: Middle East and Africa: Veterinary Vaccines Market: Breakup by Country (in %), 2022
- Figure 85: Middle East and Africa: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 86: Global: Veterinary Vaccines Industry: SWOT Analysis
- Figure 87: Global: Veterinary Vaccines Industry: Value Chain Analysis
- Figure 88: Global: Veterinary Vaccines Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Veterinary Vaccines Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Veterinary Vaccines Market Forecast: Breakup by Vaccine Type (in Million US$), 2023-2028
- Table 3: Global: Veterinary Vaccines Market Forecast: Breakup by Technology (in Million US$), 2023-2028
- Table 4: Global: Veterinary Vaccines Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
- Table 5: Global: Veterinary Vaccines Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
- Table 6: Global: Veterinary Vaccines Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 7: Global: Veterinary Vaccines Market: Competitive Structure
- Table 8: Global: Veterinary Vaccines Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.